Stock IMUC EOM PHARMACEUTICALS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders EOM Pharmaceuticals Holdings, Inc.

Equities

IMUC

US4525364026

Market Closed - OTC Markets
Other stock markets
 12:03:26 2024-05-17 pm EDT 		5-day change 1st Jan Change
0.199 USD -5.24% Intraday chart for EOM Pharmaceuticals Holdings, Inc. -5.24% -14.22%
2023 EOM Pharmaceutical Holdings Announces Topline Results of Its Covid-19 Clinical Trial of Eom613 in Brazil CI
2023 EOM Pharmaceuticals Holdings, Inc. has withdrawn its IPO in the amount of $15 million. CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ImmunoCellular Therapeutics Ltd. has Changed its Name to EOM Pharmaceuticals Holdings, Inc
CI
ImmunoCellular Therapeutics, Ltd. Announces Executive Changes, Effective October 15, 2018
CI
Immunocellular Therapeutics, Ltd. Announces Resignation of Mark A. Schlossberg and Gregg A. Lapointe from the Board of Directors
CI
ImmunoCellular Therapeutics, Ltd. Appoints David Fractor as Chief Financial Officer
CI
ImmunoCellular Therapeutics, Ltd. Announces Management Changes
CI
Immunocellular Therapeutics, Ltd. Announces the Resignation of Dr. John Yu as Chief Scientific Office
CI
ImmunoCellular Therapeutics, Ltd. Announces Executive Appointments
CI
Richard Chin Not to Stand for Re-Election as Director of Immunocellular Therapeutics, Ltd
CI
ImmunoCellular Therapeutics Appoints Steven J. Swanson as Senior Vice President, Research to Lead Stem-to-T-Cell Program
CI
ImmunoCellular Therapeutics, Ltd. Announces Resignation of Helen S. Kim as Board of Director
CI
ImmunoCellular Therapeutics, Ltd. Appoints Anthony J. Gringeri as Senior Vice President, Strategic Resources
CI
ImmunoCellular Therapeutics, Ltd. Appoints Gary S. Titus to Board of Directors
CI
ImmunoCellular Therapeutics, Ltd. Appoints Andrew Gengos as President and Chief Executive Officer and Member of the Board of Directors
CI
ImmunoCellular Therapeutics, Ltd. Announces Management Changes
CI
Jacqueline Bandwynne to Resign from ImmunoCellular Therapeutics, Ltd. as Director
CI
ImmunoCellular Therapeutics, Ltd. Appoints Richard Chin to Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMUC Stock
  4. News EOM Pharmaceuticals Holdings, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW